A PYMNTS Company

US: Rite Aid Stock Drops on Merger Report

By  |  June 12, 2017

Rite Aid’s planned merger with Walgreens Boots Alliance was having trouble winning US antitrust approval. Rite Aid’s share price dropped as much as 16.7 percent after the Capital Forum declared that the Federal Trade Commission’s staff was prepared to recommend that the agency file a lawsuit to stop the deal. Shares of Walgreens were little changed.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    A final decision on a lawsuit would be made by FTC acting Chair Maureen Ohlhausen, a Republican, and Commissioner Terrell McSweeny, a Democrat. A source close to the deal verified the report to Reuters and said that agency staff has asked companies and groups concerned about the deal for depositions and affidavits that could be used in a lawsuit aimed at stopping it.

    Full Content: Reuters

    Want more news? Subscribe to CPI’s free daily newsletterr for more headlines and updates on antitrust developments around the world.